oral tirzepatide studies tirzepatide: what actually exists, what does not, and what is coming next Oral Tirzepatide: What the Research

Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real-world effectiveness study in Canada

Alabamas attorney general recently filed a lawsuit against a medical spa alleging that it administered unapproved versions of GLP-1 weight loss drugs to patients without informing them that the formulations were not authorized by the FDA

In a dog model of obesity and insulin resistance, MEDI7219 oral tablets significantly decreased food intake, body weight and glucose excursions, validating the approach

New research in mice suggests that a weekly dose of the common corticosteroid prednisone may help weight loss.

Health Canada has approved the first generic semaglutide

Aktivera kroppens mttnadshormon GLP-1 p naturlig vg